HNC: Human Neural Circuits Electrophysiology During Cognition
ConditionPsychiatric Disorder
Trial statusRecruiting
Trial phasePhase 1
Trial typeInterventional
Biological sexAll
Age18+
SponsorStanford University
About this trial
The purpose of this study is to understand how ketamine brings about dissociative symptoms.
Eligibility criteria
Qualifiers
Patient in clinical neuro inpatient units at Stanford Medical Center
Age >18 years old
Female participants are expected to use an effective method of birth control throughout the study which includes: hormonal methods (birth control pills, patches, injections, vaginal ring or implants), barrier methods (condom or diaphragm) used with spermicide, intrauterine device (IUD), or abstinence (no sex)
Disqualifiers
Lifetime psychotic disorder
Pregnant or nursing females
Prior adverse ketamine response
Use of ketamine in past 7 days
Trial design
Treatments tested in this trial
- Ketamine Hydrochloride
Treatment groups
120 Participants
are divided into 1 treatment groupSponsors and collaborators
Source ClinicalTrials.gov